Food News and Research

RSS

FDA hears concerns on new narcotic pain pill rules

Survivors of those who died from opioid overdoses urge changes in the drugs' labels, but some patients express concerns that they might have trouble getting the drugs.

11 Feb 2013

Long-acting reversible contraception with progestin may increase risk of type 2 diabetes in women

A first-of-its-kind study by researchers at the Keck School of Medicine of the University of Southern California (USC) indicates that healthy, obese, reproductive-age women who use long-acting reversible contraception (LARC) containing the hormone progestin have a slightly increased risk for developing type 2 diabetes when compared to those who use non-hormonal contraception.

11 Feb 2013

FDA issues draft guidance on developing new treatments for Alzheimer's

Today, the U.S. Food and Drug Administration issued a proposal designed to assist companies developing new treatments for patients in the early stages of Alzheimer's disease, before the onset of noticeable (overt) dementia.

11 Feb 2013

Intra-arterial therapy no more effective than IV t-PA in treating acute ischemic stroke

A stroke survivor's chances of living independently after 90 days are not improved by the use of devices inserted into the artery to dissolve or remove a stroke-causing clot shortly after the onset of symptoms, according to a randomized controlled trial involving 656 patients.

11 Feb 2013

RNL BIO files new stem cell drug IND with KFDA to initiate phase II and III cerebral palsy trials

RNL BIO CO LTD (RNL) announced today the filing of an Investigational New Drug (IND) application with the Korean Food and Drug Administration (KFDA) to initiate clinical trials phase II and III assessing the company's RNL-Astrostem stem cell drug in patients with cerebral palsy.

11 Feb 2013

Study into spread of sexually transmitted infection in ladybirds

A study at the University of Liverpool into the spread of sexually transmitted infection in ladybirds has shown that disease risk to large populations cannot be predicted without a full understanding of the disease dynamics at small geographical scale.

10 Feb 2013

Trust in markets essential to creating more food-secure world

"Far too often we are seeing national governments overreact to market fluctuations to the extent that they are making pledges about and taking measures toward food self-sufficiency," Emery Koenig, executive vice president and chief risk officer of Cargill, writes in the Chicago Council on Global Affairs' "Global Food For Thought" blog.

10 Feb 2013

Lawmaker advances bill to create FDA Office of Wireless Health

Congressman Michael Honda (D., Calif.), who has been representing Silicon Valley in the U.S. House of Representatives for the past 12 years, recently submitted a bill asking for Congress to create and fund a new office at the U.S. Food and Drug Administration, which would be called the Office of Wireless Health.

10 Feb 2013

Roundup: Assisted suicide legalization urged; Abortion bill tensions in Wash., Ore.; Budget squeezes in Ga., Conn.

A push for the legalization of physician-assisted suicide is under way in a half-dozen states where proponents say they see strong support for allowing doctors to prescribe mentally competent, dying individuals with the medications needed to end their own lives. ... Groups such as Compassion & Choices, a national end-of-life advocacy organization, have been working to advance the cause.

10 Feb 2013

Celgene's Pomalyst receives FDA approval for treatment of multiple myeloma

The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.

10 Feb 2013

Celgene receives FDA approval for POMALYST to treat multiple myeloma

Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved POMALYST brand therapy (pomalidomide) for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.

10 Feb 2013

Shire, Impax resolve pending generic Adderall XR litigation

Impax Laboratories, Inc. today announced that it has settled all pending litigation with Shire LLC and Shire Laboratories, Inc. relating to supply of its authorized generic Adderall XR under the parties' License and Distribution Agreement that was signed in January 2006.

10 Feb 2013

International Association of Eating Disorders Professionals to kick off 27th annual symposium

The International Association of Eating Disorders Professionals (iaedp) kicks off its 27th annual Symposium March 21-24 at the Westin Lake Las Vegas Resort and Spa and will feature five nationally recognized professionals addressing new treatments and research concerning eating disorders.

10 Feb 2013

MMRF joins multiple myeloma community in celebrating FDA accelerated approval of Pomalyst

The Multiple Myeloma Research Foundation (MMRF) today joined the multiple myeloma community in celebrating the U.S. Food and Drug Administration's (FDA) decision to grant accelerated approval of Pomalyst (Celgene Corporation, pomalidomide) for the treatment of patients with relapsed and refractory multiple myeloma who no longer respond to currently available treatments.

10 Feb 2013

Shire commences ABH001 Phase 3 study in Epidermolysis Bullosa

Shire plc, today announced the initiation of a Phase 3 study designed to evaluate the efficacy and safety of ABH001, its dermal substitute therapy, for the treatment of non-healing wounds in patients with Epidermolysis Bullosa (EB), a group of rare genetic skin disorders that begin to manifest at birth or early childhood and occur in approximately 19 per 1 million live births in the US.

10 Feb 2013

First Edition: February 8, 2013

Today's early morning highlights from the major news organizations, including reports about Marilyn Tavenner's nomination to run Medicare and the Catholic bishops' rejection of the Obama administration's contraception plan announced last week.

9 Feb 2013

Ongoing conflict aggravating health of Syrians, WHO warns

The WHO on Tuesday "warned that the ongoing conflict in Syria, which will soon enter its third year, will lead to a sharp spike in the number of people needing urgent aid, including food, clean water and vital medical services," the U.N. News Centre reports.

9 Feb 2013

Emphasis on 'How' missing from 'IF campaign' against global hunger

The "Enough Food for Everyone If" campaign (IF campaign), "supported by a coalition of more than 100 development organizations, has identified four priorities on aid, land, tax avoidance and market transparency," Zahid Torres-Rahman, founder of Business Fights Poverty, writes in the Guardian Sustainable Business blog.

9 Feb 2013

Certain nutrients may play an underlying role in short and long sleep duration

"You are what you eat," the saying goes, but is what you eat playing a role in how much you sleep? Sleep, like nutrition and physical activity, is a critical determinant of health and well-being. With the increasing prevalence of obesity and its consequences, sleep researchers have begun to explore the factors that predispose individuals to weight gain and ultimately obesity.

9 Feb 2013

WFP resumes food aid delivery in Northern Mali amid NGO warnings of increasing need

"Communities in northern Mali are in need of humanitarian intervention following the recent military operations in Gao and Timbuktu, leading non-governmental organizations (NGOs) to call for deliveries of food aid, fuel and even currency notes," Inter Press Service reports.

7 Feb 2013